Healthcare and Pharmaceuticals

Growth is guaranteed in this sector and opportunities will be numerous.

The healthcare market is an extremely profitable area of investment.

We are witnessing a consumer drive towards health and fitness, longer life expectations and a desire for higher lifestyle standards. In addition, we have an ageing UK population which will increase from the current 4.7 million over 75 year olds to 8.2 million by 2030.

Public finances are also under pressure and we should see changes to government policy which will alter market dynamics and present opportunities for investors.

In particular, we expect the trend towards deregulation and more outsourcing to gather pace. Businesses that can reduce NHS costs through their product or service offerings are the type of business we will look to invest in. For example:

businesses focused on reducing the disease burden through prevention, management, education, or early identification
and businesses providing support services to PCTs such as claims processing businesses or invoice validation businesses.

The pharmaceutical market is an area where Gresham has both a superb track record of delivering value to all shareholders, and a continued desire to invest.

Businesses providing later stage pharmaceutical products or pharmaceutical services are of particular interest.

For further information please contact:
Anthony Bull

Two examples, one current, one realised:

Minivator

The 2nd largest provider of stair lifts to the less able and disabled population in the UK. In its sector it is the third largest in the world.

Penn Pharmaceuticals

A drug delivery business providing fully integrated pharmaceutical services. Based in Tedegar, south Wales, the business tests, develops and manufactures products for companies including an international range of customers.